SCHEMBL23552039

SCHEMBL23552039

COC(=O)C(CO)C[C@@H](C)Cc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.55
▸ CYP2C9 P11712 2/20 0.55
▸ THRB P10828 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ CA12 O43570 1/20 0.48
▸ CA2 P00918 1/20 0.48
▸ CA7 P43166 1/20 0.48
▸ CA9 Q16790 1/20 0.48
▸ CA14 Q9ULX7 1/20 0.48
▸ KMT2A Q03164 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ BIRC2 Q13490 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ CYP3A4 P08684 2/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ TRPA1 O75762 1/20 0.45
▸ MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23552087 1.00 ALDH1A1 (0.55) ALDH1A1CYP2C9THRBCYP2C19HSD17B10
SCHEMBL23551743 1.00 ALDH1A1 (0.55) ALDH1A1CYP2C9THRBCYP2C19HSD17B10
SCHEMBL3596338 0.85 ALDH1A1 (0.57) ALDH1A1CYP2C9THRBCYP2C19HSD17B10
SCHEMBL23552106 0.84 ALDH1A1 (0.50) ALDH1A1CYP2C9THRBCYP2C19HSD17B10
SCHEMBL23552058 0.84 ALDH1A1 (0.50) ALDH1A1CYP2C9THRBCYP2C19HSD17B10
SCHEMBL13386048 0.83 ALDH1A1 (0.55) ALDH1A1CYP2C9THRBCYP2C19HSD17B10
Hydrochloric Acid SCHEMBL23525225 0.82 ALDH1A1 (0.49) ALDH1A1CYP2C9THRBCYP2C19HSD17B10
Hydrochloric Acid SCHEMBL23525493 0.82 ALDH1A1 (0.49) ALDH1A1CYP2C9THRBCYP2C19HSD17B10
Hydrochloric Acid SCHEMBL23525226 0.82 ALDH1A1 (0.49) ALDH1A1CYP2C9THRBCYP2C19HSD17B10
Hydrochloric Acid SCHEMBL23525229 0.82 ALDH1A1 (0.49) ALDH1A1CYP2C9THRBCYP2C19HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210188906-A1 TUBULYSIN ANALOGUES AS ANTICANCER AGENTS AND PAYLOADS FOR ANTIBODY-DRUG CONJUGATES AND METHODS OF TREATMENT THEREWITH WILLIAM MARSH RICE UNIVERSITY (US) 2021-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188906-A1 TUBULYSIN ANALOGUES AS ANTICANCER AGENTS AND PAYLOADS FOR ANTIBODY-DRUG CONJUGATES AND METHODS OF TREATMENT THEREWITH TEK, CD2BP2, SDCBP ALDH1A1 3809/4885CYP2C9 4812/4885THRB 1824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback